About Karen

This author has not yet filled in any details.
So far Karen has created 15 blog entries.

Seeking Physician Input on Using Expanded Access To Experimental Drugs for Their Patients

Clinical Research Pathways Needs Assessment Survey Aims to Assist Physicians ATLANTA, Ga., June 26, 2018— Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program. Under the U.S. Food and Drug Administration's expanded [...]

2018-07-19T17:08:43+00:00June 26, 2018|News|

Clinical Research Pathways Names Two New Directors

ATLANTA, Ga., June 5, 2018 — Clinical Research Pathways has appointed two new members to its board of directors: Anne B. Cropp of Early Access Care and Andrew McFadyen of The Isaac Foundation and Equal Access for Rare Disorders. The former WCG Foundation, Clinical Research Pathways is a public charity that works to improve health and [...]

2018-07-02T16:11:41+00:00June 5, 2018|News|

WCG Foundation Is Now Clinical Research Pathways

N E W S   R E L E A S E FOR IMMEDIATE RELEASE                  May 23, 2018 WCG Foundation Is Now Clinical Research Pathways New name reflects focus on expanded access and inclusion in research. ATLANTA, Ga., May 23, 2018—WCG Foundation is now Clinical Research Pathways, a name that better reflects the public charity’s emphasis [...]

2018-07-02T16:01:14+00:00May 22, 2018|News|

Republicans Get Ready to Vote on “Right-to-Try” Bill Again

Published March 19, 2018 by The American Journal of Managed Care The right-to-try bill, which suffered a surprise 259-140 defeat in the House of Representatives last week, is scheduled for another vote this week, perhaps as early as Wednesday. On Monday, the House Committee on Rules was scheduled to meet late in the day to [...]

2018-07-02T15:04:00+00:00March 19, 2018|News|

Weighing the Merits of Right-to-Try Laws and FDA’s Expanded Access Program

Published February 27, 2018 by The American Journal of Managed Care Just a month before attendees gathered in Philadelphia, Pennsylvania, for the annual meeting of Patient-Centered Oncology Care®, legislators in the state’s capital of Harrisburg made it the 38th to pass a right-to-try law. That was 6 states in 2017 alone.1 Championed by conservative groups like [...]

2018-07-02T14:47:26+00:00February 27, 2018|News|

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF ATLANTA, Ga., Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients. The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They [...]

2018-07-02T14:49:35+00:00January 9, 2018|News|

Right to Try Bills Push the Needle on Risk’ –  panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss risks associated with Right-to-Try legislation

Published December 24, 2017 by OncLive "Congressional “right-to-try” legislation could make investigational drugs available to desperately ill patients sooner in the trials process, but there are substantial risks, said a panel of experts at the Patient-Centered Oncology Conference, held November 16-17 in Philadelphia, Pennsylvania. Earlier in the clinical trials process, less is known about the [...]

2018-07-02T14:50:44+00:00December 24, 2017|News|

Panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss Right to Try bill at Patient Centered Oncology Care 2017 meeting

Published November 17, 2017 by HCA News "Marjorie A. Speers, Executive Director of the WCG Foundation, also had problems with Right to Try laws. Under the existing system, the process encourages deliberate decisions: first, the patient and their physician decide they want to pursue a drug undergoing clinical trial; then, they request that access from [...]

2018-07-02T14:51:59+00:00November 17, 2017|News|

WCGF Director David Farber, JD provides expertise in NPR’s 1A Discussion of Expanded Access and Senate Right-To-Try Legislation

David Farber, Partner in the FDA and Life Sciences practice of the law firm King and Spalding, and a Director of WCGF lent his expertise to a nuanced discussion of the questions surrounding expanded access to experimental drugs for patients seeking drugs outside of clinical trials.  The program, which provided multiple views on state Right-To-Try [...]

2018-07-02T14:55:47+00:00August 7, 2017|News|
Load More Posts